writing

UNIFIED TRIAL MANAGEMENT

Cognizant Shared Investigator Platform

Roche cuts its global feasibility process by 36% with Cognizant SIP

A standardized feasibility process powered by Cognizant® Shared Investigator Platform (SIP) drives efficiencies while improving the user experience for both site and sponsor teams.

Learn more

<h3><span class="text-regular">A new way forward</span></h3> <h5>In light of the pandemic and technology breakthroughs such as AI and remote collaboration, life sciences organizations around the world are reconsidering how they conduct clinical trials.</h5> <h5>Cognizant’s&nbsp;<a href="https://www.sharedinvestigator.com/siteminderagent/dmspages/sip/index.html?TYPE=33554433\&amp;REALMOID=06-00006235-3b16-1578-8c8d-d0950a7690fd\&amp;GUID=\&amp;SMAUTHREASON=0\&amp;METHOD=GET\&amp;SMAGENTNAME=-SM-Xi6LRpV3lonj3vgmEfUFRJ9QffczVpWWdyMuUJN9fhxi%2bh4tH9IhvrqstfbN1hul\&amp;TARGET=-SM-http%3a%2f%2fwww%2esharedinvestigator%2ecom%2f" target="_blank">Shared Investigator Platform</a>&nbsp;supports a new approach for streamlining clinical trials. As the industry’s first open, SaaS-based clinical ecosystem, Cognizant SIP connects sponsors, sites and technology providers working at home or other locations. It does so all from one place, with one sign-in.</h5> <h5>Many leading life sciences companies have joined SIP, committing to a shared vision of common workflows, training and documents. Sponsors and sites report improved efficiencies and quicker study start-ups. The result? Faster time to market for new therapies—and more time helping patients.</h5> <h5>Learn more about our&nbsp;<a href="/content/cognizant-dot-com/us/en/industries/life-sciences-technology-solutions.html" target="_self">Life Sciences</a>&nbsp;solutions for your business.</h5>
Cognizant SIP Soars Past 300,000 Users

With over 300,000 users worldwide, Cognizant SIP’s remarkable journey continues.

View infographic

BUSINESS INTELLIGENCE
<h3>Recently published insights</h3>
A robot holds a red light in front of a computer screen, illuminating the display with a vibrant glow.
From vision to momentum
From vision to momentum

A retrospective on the SIP's journey-and the road ahead

mountain
Today's new normal
Today's new normal

Cognizant SIP for COVID-19

<h3>Related thinking</h3>
Jose Manuel Perez Mosquera

With the Shared Investigator Platform, we have one point of access for all studies across different sponsors, which is exactly what we needed to simplify management and improve efficiency of our clinical trials.

Jose Manuel Perez Mosquera
Clinical Research Manager
CHUAC-Complejo Hospitalario Universitario A Coruña

LIFE SCIENCES MANAGEMENT
<h3>Leadership</h3>

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing.

Let’s talk about how digital can work for your business.